Cargando…
Isotoosendanin exerts inhibition on triple-negative breast cancer through abrogating TGF-β-induced epithelial–mesenchymal transition via directly targeting TGFβR1
As the most aggressive breast cancer, triple-negative breast cancer (TNBC) is still incurable and very prone to metastasis. The transform growth factor β (TGF-β)-induced epithelial–mesenchymal transition (EMT) is crucially involved in the growth and metastasis of TNBC. This study reported that a nat...
Autores principales: | Zhang, Jingnan, Zhang, Ze, Huang, Zhenlin, Li, Manlin, Yang, Fan, Wu, Zeqi, Guo, Qian, Mei, Xiyu, Lu, Bin, Wang, Changhong, Wang, Zhengtao, Ji, Lili |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10372922/ https://www.ncbi.nlm.nih.gov/pubmed/37521871 http://dx.doi.org/10.1016/j.apsb.2023.05.006 |
Ejemplares similares
-
Cyclooxygenase-2 overexpression abrogates the antiproliferative effects of TGF-β
por: Enders, G A
Publicado: (2007) -
Caveolin-1 abrogates TGF-β mediated hepatocyte apoptosis
por: Meyer, C, et al.
Publicado: (2013) -
HCK promotes glioblastoma progression by TGFβ signaling
por: Wang, Zhenlin, et al.
Publicado: (2020) -
MicroRNA-133b targets TGFβ receptor I to inhibit TGF-β-induced epithelial-to-mesenchymal transition and metastasis by suppressing the TGF-β/SMAD pathway in breast cancer
por: WANG, SHENGJIE, et al.
Publicado: (2019) -
TGF-β(1 )induced epithelial to mesenchymal transition (EMT) in human bronchial epithelial cells is enhanced by IL-1β but not abrogated by corticosteroids
por: Doerner, Astrid M, et al.
Publicado: (2009)